Skip to main content

Advertisement

Log in

Serum Eosinophil-Derived Neurotoxin (EDN) in Diagnosis and Evaluation of Severity and Bronchial Hyperresponsiveness in Childhood Asthma

  • Published:
Lung Aims and scope Submit manuscript

Abstract

This study sought to evaluate the use of serum eosinophil-derived neurotoxin (EDN), which has been proposed as a marker of airway inflammation in asthma in the diagnosis and evaluation of the severity and bronchial hyperresponsiveness in childhood asthma. We studied 72 children with atopic asthma, 36 children with nonatopic asthma, and 43 healthy controls. Skin prick tests, pulmonary function tests, and methacholine challenge tests were performed, in addition to total eosinophil count, serum ECP, and EDN being measured in all subjects. EDN levels were significantly higher in the atopic asthma group than those in the nonatopic asthma group or control group (p < 0.001), as were ECP levels (p < 0.001). EDN levels differed more significantly among groups divided by asthma severity (p < 0.001) than did ECP levels for these groups (p < 0.05). For the groups divided according to bronchial hyperresponsiveness, both EDN and ECP levels were significantly different (p < 0.005 and p < 0.01, respectively). Significant correlations were found between EDN and PC20 (γ = −0.281; p < 0.001), between ECP and PC20 (γ = −0.274; p < 0.005), and between EDN and ECP (γ = 0.443; p < 0.001). In conclusion, serum EDN, as another marker of eosinophilic inflammation together with ECP, may aid in the diagnosis of asthma, especially atopic asthma, and in the evaluation of the severity and bronchial hyperresponsiveness in childhood asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. American Thoracic Society (2000) Guidelines for Methacholine and Exercise Challenge Testing-1999. Am J Respir Crit Care Med 161:309–329

    Google Scholar 

  2. Bacharier LB, Strunk RC, Mauger D, et al. (2004) Classifying asthma severity in children mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 170:426–432

    Article  PubMed  Google Scholar 

  3. Backman A (1994) Skin tests for epidemiologic studies. Allergy 49:493–494

    PubMed  CAS  Google Scholar 

  4. Bousquet J, Chanez P, Lacoste JY, et al. (1990) Eosinophilic inflammation in asthma. N Engl J Med 323:1033–1039

    Article  PubMed  CAS  Google Scholar 

  5. Brown WG, Halonen MJ, Kaltenborn WT, Barbee RA (1979) The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample. J Allergy Clin Immunol 63:328–335

    Article  PubMed  CAS  Google Scholar 

  6. Ferguson AC, Vaughan R, Brown H, Curtis C (1995) Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 95:23–28

    Article  PubMed  CAS  Google Scholar 

  7. Fujisawa T, Terada A, Atsuta J, et al. (1998) Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma. Clin Exp Allergy 28:19–25

    Article  PubMed  CAS  Google Scholar 

  8. Gleich GJ (2000) Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105:651–663

    Article  PubMed  CAS  Google Scholar 

  9. Global Initiative for Asthma (GINA) (1995) Global strategy for asthma management and prevention, updated 2002, 2004, 2005. Washington, DC: National Institutes of Health, NIH Publication No. 02-3659. Available at http://www.ginasthma.org (accessed 10 March 2006)

  10. Gruber W, Eber E, Pfleger A, et al. (1999) Serum eosinophil cationic protein and bronchial responsiveness in pediatric and adolescent asthma patients. Chest 116:301–305

    Article  PubMed  CAS  Google Scholar 

  11. Hohlfeld JM, Schmiedl A, Erpenbeck VJ, Venge P, Krug N (2004) Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. J Allergy Clin Immunol 113:496–502

    Article  PubMed  CAS  Google Scholar 

  12. Joseph-Bowen J, Klerk N, Holt PG, Sly PD (2004) Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood. J Allergy Clin Immunol 114:1040–1045

    Article  PubMed  CAS  Google Scholar 

  13. Lonnkvist K, Hellman C, Lundahl J, et al. (2001) Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J Allergy Clin Immunol 107:812–817

    Article  PubMed  CAS  Google Scholar 

  14. Lowhagen O, Wever AMJ, Lusuardi M, et al. (2002) The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients. Respir Med 96:95–101

    Article  PubMed  CAS  Google Scholar 

  15. Martinez FD (1999) Present and future treatment of asthma in infants and young children. J Allergy Clin Immunol 104:169–174

    Article  PubMed  CAS  Google Scholar 

  16. Morioka J, Kurosawa M, Inamura H, et al. (2000) Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthma. Int Arch Allergy Immunol 122:49–57

    Article  PubMed  CAS  Google Scholar 

  17. Niimi A, Amitani R, Suzuki K, et al. (1998) Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 28:233–240

    Article  PubMed  CAS  Google Scholar 

  18. Park JW, Kim CW, Hong CS (1997) Clinical significance of eosinophil cationic protein (ECP) in bronchial asthma. J Korean Soc Allergol 17:260–269

    Google Scholar 

  19. Park Y, Kang H, Kang EK, Koh YY (2002) Blood eosinophil and serum eosinophil cationic protein as a marker of bronchial hyperresponsiveness in children with suspected asthma. J Korean Pediatr Soc 45:1577–1584

    Article  Google Scholar 

  20. Plager DA, Adolphson CR, Gleich GJ (2001) A novel human homolog of eosinophil major basic protein. Immunol Rev 179:192–202

    Article  PubMed  CAS  Google Scholar 

  21. Prehn A, Seger RA, Faber J, et al. (1998) The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr Allergy Immunol 9:197–203

    PubMed  CAS  Google Scholar 

  22. Rao R, Frederick JM, Enander I, et al. (1996) Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma. Clin Exp Allergy 26:789–793

    Article  PubMed  CAS  Google Scholar 

  23. Remes S, Korppi M, Remes K, et al. (1998) Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy. Pediatr Pulmonol 25:167–174

    Article  PubMed  CAS  Google Scholar 

  24. Sedgwick JB, Vrtis RF, Jansen KJ, et al. (2004) Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 114:568–574

    Article  PubMed  CAS  Google Scholar 

  25. Sorkness C, McGill K, Busse WW (2002) Evaluation of serum eosinophil cationic protein as a predictive marker for asthma exacerbation in patients with persistent disease. Clin Exp Allergy 32:1355–1359

    Article  PubMed  CAS  Google Scholar 

  26. Vanto T, Koskinen P (1998) Serum eosinophil cationic protein in the evaluation of asthma severity in children. Allergy 53:415–419

    PubMed  CAS  Google Scholar 

  27. Vatrella A, Ponticiello A, Parrella R, et al. (1996) Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. Allergy 51:547–555

    PubMed  CAS  Google Scholar 

  28. Wolthers OD (2003) Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 14:248–254

    Article  PubMed  CAS  Google Scholar 

  29. Yoon KA, Lim HS, Kim H, Koh YY (1993) normal predicted values of pulmonary function test in Korean school-aged children. J Korean Pediatr Soc 36:25–37

    Google Scholar 

  30. Zimmerman B, Lanner A, Enander I, et al. (1993) Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 23:564–570

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Myung Hyun Sohn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, K.W., Lee, K.E., Kim, E.S. et al. Serum Eosinophil-Derived Neurotoxin (EDN) in Diagnosis and Evaluation of Severity and Bronchial Hyperresponsiveness in Childhood Asthma. Lung 185, 97–103 (2007). https://doi.org/10.1007/s00408-006-0054-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-006-0054-8

Keywords

Navigation